Logmore, a Finnish provider of supply chain analytics solutions, announced on Wednesday the launch of a new logistics monitor designed for COVID-19 vaccine delivery.
Logmore Dry Ice, a high-spec version of the company's original data recorder, has been adapted for cold and sub-zero conditions. It is designed for sensitive shipments such as COVID-19 vaccines which require deep freeze storage of as low as -80ºC throughout their journey.
The logger has an additional sensor connected to it with a cable. By placing only the external sensor inside the box, the device can monitor internal temperatures despite remaining outside the box -- allowing it to handle far lower temperatures than comparable products.
The device's ability to monitor temperature, humidity, shocks, tilt and light in real-time will help ensure that life-saving vaccines can be distributed in optimum condition, Logmore said.
FDA grants priority review for GSK's gepotidacin gonorrhoea indication
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement
FDA lifts pause on Valneva's chikungunya vaccine IXCHIQ for elderly, updates prescribing information
Anixa Biosciences begins US FDA approved IND transfer to support Phase 2 breast cancer vaccine trial
Pfizer and BioNTech receive EU regulatory backing for LP.8.1-adapted COVID-19 vaccine
Sanofi to acquire Vicebio for USD1.15bn to strengthen respiratory vaccine pipeline
Bavarian Nordic chikungunya vaccine enters Health Canada review process
SK bioscience submits IND for Phase 1/2 clinical trial of new influenza vaccine candidate
GC Biopharma secures Vietnamese approval for varicella vaccine BARYCELA
GSK announces submission of RSV vaccine Arexvy for FDA review
PharmaJet signs MOU with Egyptian UPA and EVA Pharma to introduce needle-free vaccine delivery
Centivax raises USD45m to commercialise universal flu vaccine
CyanVac's nasal COVID vaccine shows promise in phase 1 trial
hVIVO supports Cidara Therapeutics' positive Phase 2b influenza study results